A couple things;
As far as seller goes its hard to say what he has left; Dempsey quit on 1/24 12. At the time he had 6.6 million shares. He doesn't have to file cause he is under 5% and 10-k no longer shows his position since he is not an employee.
Not likely or smart for Ma to buy in open market. He has 400k of stock options he can exercise in the next 60 day which are under present open market price. So........
Also, I have never thought management was overpaid, but there was some generous cash bonuses paid to some (ma 100k and old head of vasohealthcare over 100k). No one should have gotten any bonus considering company lost profitability in last statement. Especially since stock based compensation is a little too generous.
Foreign sales are the key now. That is where the growth is and they were the only bright spot. If we can get new trials, cms coverage, new designation for eecp, more ge products, or more ge type company's products for our sales force......lots of potential good events.
Also, new great hire from Seimans has not had such a great start. Big weakness in his division. Again, another stock give away that has done nothing. Did we really need to pay for this guys resume? Results please!!!!!!!
those are the numbers i looked at when i threw out the hypothetical "short squeeze" from current shareholders. when considering what he had when he left/last reported and looking at the average daily volume - i thought there might be around 1.5MM shares left (if memory servers). regardless - if he is the seller, his position should be greatly reduced and if volume increases, the buyback should close the position in short order.